title: Consensus document on allergic conjunctivitis (DECA).
abstract: Allergic conjunctivitis (AC) is an inflammatory disease of the conjunctiva caused mainly by an IgE-mediated mechanism. It is the most common type of ocular allergy. Despite being the most benign form of conjunctivitis, AC has a considerable effect on patient quality of life, reduces work productivity, and increases health care costs. No consensus has been reached on its classification, diagnosis, or treatment. Consequently, the literature provides little information on its natural history, epidemiological data are scarce, and it is often difficult to ascertain its true morbidity. The main objective of the Consensus Document on Allergic Conjunctivitis (Documento dE Consenso sobre Conjuntivitis Alérgica [DECA]), which was drafted by an expert panel from the Spanish Society of Allergology and Spanish Society of Ophthalmology, was to reach agreement on basic criteria that could prove useful for both specialists and primary care physicians and facilitate the diagnosis, classification, and treatment of AC. This document is the first of its kind to describe and analyze aspects of AC that could make it possible to control symptoms.
authors.forename: M C
authors.initials: MC
authors.lastname: Sánchez-Hernández
authors.forename: J
authors.initials: J
authors.lastname: Montero
authors.forename: C
authors.initials: C
authors.lastname: Rondon
authors.forename: J M
authors.initials: JM
authors.lastname: Benitez del Castillo
authors.forename: E
authors.initials: E
authors.lastname: Velázquez
authors.forename: J M
authors.initials: JM
authors.lastname: Herreras
authors.forename: B
authors.initials: B
authors.lastname: Fernández-Parra
authors.forename: J
authors.initials: J
authors.lastname: Merayo-Lloves
authors.forename: A
authors.initials: A
authors.lastname: Del Cuvillo
authors.forename: F
authors.initials: F
authors.lastname: Vega
authors.forename: A
authors.initials: A
authors.lastname: Valero
authors.forename: C
authors.initials: C
authors.lastname: Panizo
authors.forename: J
authors.initials: J
authors.lastname: Montoro
authors.forename: V
authors.initials: V
authors.lastname: Matheu
authors.forename: M
authors.initials: M
authors.lastname: Lluch-Bernal
authors.forename: M L
authors.initials: ML
authors.lastname: González
authors.forename: R
authors.initials: R
authors.lastname: González
authors.forename: M T
authors.initials: MT
authors.lastname: Dordal
authors.forename: I
authors.initials: I
authors.lastname: Dávila
authors.forename: C
authors.initials: C
authors.lastname: Colás
authors.forename: P
authors.initials: P
authors.lastname: Campo
authors.forename: E
authors.initials: E
authors.lastname: Antón
authors.forename: A
authors.initials: A
authors.lastname: Navarro
mesh_terms: D000486:Allergy and Immunology / Q000592:standards*; D018926:Anti-Allergic Agents / Q000592:standards / Q000627:therapeutic use*; D003233:Conjunctivitis, Allergic / Q000145:classification / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*; D003937:Diagnosis, Differential; D006801:Humans; D007167:Immunotherapy / Q000379:methods* / Q000592:standards; D011237:Predictive Value of Tests; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D018926:Anti-Allergic Agents